[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate

C36H49FN6O6 — CID 146185022

IUPAC[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate
SMILESC/C(=C\c1cc(F)cc(N2CCN(C(=O)Cn3cccn3)CC2)c1)[C@H]1OC(=O)C[C@H](O)CC[C@H](C)C(OC(=O)N2CCNCC2)/C=C/[C@@H]1C
InChIInChI=1S/C36H49FN6O6/c1-25-5-7-31(44)23-34(46)49-35(26(2)6-8-32(25)48-36(47)42-13-10-38-11-14-42)27(3)19-28-20-29(37)22-30(21-28)40-15-17-41(18-16-40)33(45)24-43-12-4-9-39-43/h4,6,8-9,12,19-22,25-26,31-32,35,38,44H,5,7,10-11,13-18,23-24H2,1-3H3/b8-6+,27-19+/t25-,26-,31+,32?,35-/m0/s1
InChIKeyYQTUXPFBKPSDID-GQXJAOAGSA-N
MW680.82 g/mol
LogP3.47
Rot. Bonds6

About [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate

[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate (PubChem CID 146185022) has the molecular formula C36H49FN6O6 and a molecular weight of 680.82 g/mol. Its IUPAC name is [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate.

Molecular Properties

Compound Name[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate
PubChem CID146185022
Molecular FormulaC36H49FN6O6
Molecular Weight680.82 g/mol
Exact Mass680.37
IUPAC Name[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate
SMILESC/C(=C\c1cc(F)cc(N2CCN(C(=O)Cn3cccn3)CC2)c1)[C@H]1OC(=O)C[C@H](O)CC[C@H](C)C(OC(=O)N2CCNCC2)/C=C/[C@@H]1C
InChIInChI=1S/C36H49FN6O6/c1-25-5-7-31(44)23-34(46)49-35(26(2)6-8-32(25)48-36(47)42-13-10-38-11-14-42)27(3)19-28-20-29(37)22-30(21-28)40-15-17-41(18-16-40)33(45)24-43-12-4-9-39-43/h4,6,8-9,12,19-22,25-26,31-32,35,38,44H,5,7,10-11,13-18,23-24H2,1-3H3/b8-6+,27-19+/t25-,26-,31+,32?,35-/m0/s1
InChIKeyYQTUXPFBKPSDID-GQXJAOAGSA-N
XLogP3.47
TPSA129.47 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds6
Heavy Atoms49
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500680.82
LogP ≤ 53.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate?
The IUPAC name of [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate (CID 146185022) is [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate.
What is the SMILES notation for [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate?
The canonical SMILES for [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate is C/C(=C\c1cc(F)cc(N2CCN(C(=O)Cn3cccn3)CC2)c1)[C@H]1OC(=O)C[C@H](O)CC[C@H](C)C(OC(=O)N2CCNCC2)/C=C/[C@@H]1C.
What is the InChIKey of [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate?
The InChIKey is YQTUXPFBKPSDID-GQXJAOAGSA-N. The full InChI is InChI=1S/C36H49FN6O6/c1-25-5-7-31(44)23-34(46)49-35(26(2)6-8-32(25)48-36(47)42-13-10-38-11-14-42)27(3)19-28-20-29(37)22-30(21-28)40-15-17-41(18-16-40)33(45)24-43-12-4-9-39-43/h4,6,8-9,12,19-22,25-26,31-32,35,38,44H,5,7,10-11,13-18,23-24H2,1-3H3/b8-6+,27-19+/t25-,26-,31+,32?,35-/m0/s1.
What are the key properties of [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate?
[(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate has a molecular weight of 680.82 g/mol, XLogP of 3.47, 6 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3S,4E,7S,10R)-2-[(E)-1-[3-fluoro-5-[4-(2-pyrazol-1-ylacetyl)piperazin-1-yl]phenyl]prop-1-en-2-yl]-10-hydroxy-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] piperazine-1-carboxylate is sourced from PubChem (CID 146185022), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).